Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.76M | -92.98M | -73.90M | -69.12M | -64.20M |
| Total Depreciation and Amortization | 38.00K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.78M | 57.54M | 56.64M | 56.69M | 54.02M |
| Change in Net Operating Assets | 1.28M | 6.27M | 1.70M | 1.45M | 10.23M |
| Cash from Operations | -39.66M | -29.18M | -15.56M | -10.99M | 57.00K |
| Capital Expenditure | -77.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -4.65M | -4.65M | -4.65M | -4.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -163.09M | -172.95M | -116.45M | -26.29M | 73.54M |
| Cash from Investing | -163.16M | -177.59M | -121.09M | -30.94M | 68.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.56M | 130.96M | 130.98M | 130.98M | 129.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -250.00K | -250.00K | -250.00K | -- | -- |
| Cash from Financing | 2.31M | 130.71M | 130.73M | 130.98M | 129.23M |
| Foreign Exchange rate Adjustments | 51.00K | 46.00K | 42.00K | -231.00K | -335.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.46M | -76.01M | -5.88M | 88.82M | 197.85M |